[1]
Sowjanya, T. et al. 2026. Heterocyclic Tyrosine Kinase Inhibitors: Structural Insights and Medicinal Chemistry Strategies in Cancer, Immune-Mediated Disorders and Myeloproliferative Neoplasms. Adolescência e Saúde. (Oct. 2026), 2011–2020.